Financière de Tubize S.A. Stock

Equities

TUB

BE0003823409

Pharmaceuticals

Real-time Euronext Bruxelles 06:41:26 2024-04-26 am EDT 5-day change 1st Jan Change
91.8 EUR -1.18% Intraday chart for Financière de Tubize S.A. -0.11% +28.03%
Sales 2022 0.01 0.01 Sales 2023 - Capitalization 3.19B 2.98B
Net income 2022 85M 79.24M Net income 2023 88M 82.04M EV / Sales 2022 392,371,878,420 x
Net Debt 2022 46.73M 43.56M Net Debt 2023 78.63M 73.3M EV / Sales 2023 -
P/E ratio 2022
37 x
P/E ratio 2023
36.2 x
Employees 3
Yield 2022
1.21%
Yield 2023
1.35%
Free-Float 29.31%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.18%
1 week-0.11%
Current month+2.11%
1 month+1.21%
3 months+20.79%
6 months+44.79%
Current year+28.03%
More quotes
1 week
90.90
Extreme 90.9
93.00
1 month
88.30
Extreme 88.3
94.00
Current year
71.70
Extreme 71.7
94.00
1 year
60.80
Extreme 60.8
94.00
3 years
60.80
Extreme 60.8
100.80
5 years
49.80
Extreme 49.8
100.80
10 years
48.05
Extreme 48.045
100.80
More quotes
Members of the board TitleAgeSince
Director/Board Member - -
Director/Board Member 74 81-12-31
Director/Board Member 58 18-12-31
More insiders
Date Price Change Volume
24-04-26 91.8 -1.18% 15 246
24-04-25 92.9 +1.75% 24,624
24-04-24 91.3 -1.30% 16,614
24-04-23 92.5 +0.11% 5,046
24-04-22 92.4 +0.54% 43,161

Real-time Euronext Bruxelles, April 26, 2024 at 06:41 am EDT

More quotes
Financière de Tubize S.A. is a holding company that owns 36.24% of the listed biopharmacy group UCB.
Calendar
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
92.9 EUR
Average target price
118.2 EUR
Spread / Average Target
+27.29%
Consensus